Substituted heterocyclyl derivatives as CDK inhibitors Grant US-11174232-B2 United States of America 16 Nov 2021
Substituted heterocyclyl derivatives as CDK inhibitors Grant US-10689347-B2 United States of America 23 Jun 2020
Pharmaceutical formulation of N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-YL]-4-[(3R,5… Application US-10420764-B2 United States of America 24 Sep 2019